Table 3

Procedural Characteristics

SES GroupPES Groupp Value
Medications during the procedure
 Heparin59.5%58.9%0.64
 Glycoprotein IIb/IIIa inhibitor40.6%40.0%0.62
 Direct thrombin inhibitor42.1%42.6%0.72
 Other4.3%4.3%0.99
Clopidogrel loading38.0%41.8%0.003
Stents implanted
 Mean ± SD1.60 ± 0.851.55 ± 0.860.043
 Median (interquartile range)1.00 (1.00–2.00)1.00 (1.00–2.00)
More than 1 stent in at least 1 lesion21.3%18.5%0.008
Total stent length, mean ± SD30.7 ± 19.728.2 ± 18.8<0.001
Statins at discharge83.9%76.6%<0.001
Clopidogrel at discharge95.7%96.8%0.07

Per patient analysis.

Abbreviations as in Table 1.

  • Clopidogrel loading defined as chronic therapy (>1 week before treatment); loading dose (≥300 mg) at least 6 h before PCI; or loading dose (≥600 mg) at least 2 h before PCI.

  • Captured in waves 2 and 3 (3,994 subjects).